These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9666213)

  • 1. Rationale for later and less postmenopausal estrogen (PME).
    Barrett-Connor E
    Aging (Milano); 1998 Apr; 10(2):158. PubMed ID: 9666213
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and coronary artery disease.
    Morris D
    Curr Opin Obstet Gynecol; 1996 Jun; 8(3):184-7. PubMed ID: 8818528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of estrogen and gestagen substitution in peri and postmenopause].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Jan; 86(5):125-8. PubMed ID: 9064729
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormone replacement therapy of menopause. When to begin? When to stop?].
    Tabaste JL
    Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy and coronary heart disease in postmenopausal women.
    King KM
    Health Care Women Int; 1996; 17(3):247-54. PubMed ID: 8852226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
    Groh KW; Stevermer JJ
    J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
    [No Abstract]   [Full Text] [Related]  

  • 8. Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women?
    Easton BT
    J Fam Pract; 2001 May; 50(5):470. PubMed ID: 11350716
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy in postmenopausal women: emerging hope for future.
    Gambhir DS; Gambhir JK
    Indian Heart J; 1998; 50(1):19-21. PubMed ID: 9583282
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogen replacement therapy in osteoporosis].
    Hirvonen E
    Duodecim; 1996; 112(22):2123-9. PubMed ID: 10605218
    [No Abstract]   [Full Text] [Related]  

  • 12. [Postmenopausal hormone therapy].
    Tiitinen A
    Duodecim; 2006; 122(5):529-32. PubMed ID: 16669439
    [No Abstract]   [Full Text] [Related]  

  • 13. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause].
    Wuttke W
    Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen--no matter how delivered--relieves postmenopausal vasomotor symptoms.
    Bachmann G
    Menopause; 2003; 10(6):494-6. PubMed ID: 14627856
    [No Abstract]   [Full Text] [Related]  

  • 16. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum progesterone and tumor necrosis factor production in postmenopausal women undergoing estrogen/medroxyprogesterone therapy.
    Stopińska-Głuszak U; Jóźwiak J; Radomski D; Głuszak O; Roszkowski PI; Malejczyk J
    Fertil Steril; 2009 Apr; 91(4 Suppl):1344-6. PubMed ID: 18554598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
    Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
    Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
    Archer DF
    Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.